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Abstract
Background: Pregnancy-related pelvic girdle and/or low back pain is a controversial syndrome because insight
in etiology and prognosis is lacking. The controversy relates to factors eliciting pain and some prognostic factors
such as the interpretation of pain at the symphysis. Recent research about treatment strategies also reflects those
various opinions, in fact suggesting there is professional uncertainty about the optimal approach. Currently,
physiotherapists often prescribe a pain-contingent treatment regime of relative rest and avoiding several day-to-
day activities. Additionally, treatment more often includes an exercise program to guide rectification of the muscle
imbalance and alignment of the pelvic girdle. Effectiveness of those interventions is not proven and the majority
of the studies are methodologically flawed. Investigators draw particular attention to biomedical factors but there
is growing evidence that important prognostic issues such as biopsychosocial factors appear to be even more
important as point of action in a treatment program.
Methods/design: This pragmatic randomized controlled trial is designed to evaluate the effectiveness of a tailor-
made treatment program with respect to biopsychosocial factors in primary care. The effect of the experimental
intervention and usual care are evaluated as they are applied in primary health care. The trial is embedded in a
cohort study that is designed as a longitudinal, prospective study, which studies prevalence, etiology, severity and
prognosis during pregnancy until one year after delivery. The present paper focuses on choices regarding
recruitment procedures, in-/exclusion criteria and the development of a well-timed intervention.
Discussion: This section briefly discusses the actions taken to minimize bias in the design, the proper time-
window for the experimental intervention and the contrast between the experimental intervention and usual
care.
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Background
Since 1962[1], diagnosis, prognosis and treatment of
pregnancy-related pelvic girdle and/or low back pain have
inflicted debate and have led to considerable differences
of opinions. Many articles appeared mainly in Interna-
tional journals and some etiological mechanisms were
hypothesized. However, the subject remains controver-
sial, mainly because insight in etiology and prognosis is
lacking. Moreover, diagnostic investigation into the exact
definition and classification of pregnancy-related pelvic
girdle and/or low back pain shows various opinions
between leading experts on this topic. The controversy
relates to factors eliciting pain[2] and prognostic factors
such as the interpretation of pain at the symphysis [3,4],
the question whether pelvic girdle pain is a syndrome sep-
arate from low back pain [4,5] and the importance of
questions about limitations in activities [6]. Also recent
research about treatment strategies reflects those various
opinions [7], in fact suggesting there is professional uncer-
tainty about the optimal approach. Investigators draw
particular attention to biomedical factors but there is
growing evidence that important prognostic issues such as
biopsychosocial factors appear to be even more important
as basis in a treatment program[8,9]. Although the group
of musculoskeletal disorders holds many different bio-
medical labels, the process of developing chronic disabil-
ity has shown surprising similarities with regard to
biopsychosocial factors [10]. For the moment, pregnancy-
related pelvic girdle and/or low back pain is a subjective
experience comprising pain and limitations in activities
for which classification criteria are insufficient in guiding
to a treatment approach (Bastiaenen et al. personal com-
munication). Results of various therapeutic interventions
have been published but excepting one recent study[11],
their effectiveness remain unproven. Furthermore, the
majority of the studies are methodologically flawed [7].
Currently, physicians and physiotherapists usually pre-
scribe a pain contingent treatment regimen of relative
(bed) rest and avoiding several day-to-day activities such
as using the stairs, bending, twisting, lifting and cycling.
Additionally, the usual treatment approach of a physio-
therapist more often includes an exercise program to
guide rectification of the muscle imbalance and alignment
of the pelvic girdle [12]. Therapists rely on knowledge of
pain duration and intensity during goal-setting for treat-
ment, for a great deal.
Why publish a study protocol
There are several reasons for publishing a study protocol
before obtaining research data. The main reason is to
reflect on the study design independently of the results.
Considerations and choices concerning methodology and
treatment can be described more detailed. The present
paper focuses on choices about recruitment procedures,
in-/exclusion criteria and the development of a well-timed
experimental intervention. We also present details about
the enrollment of women with pregnancy-related pelvic
girdle and/or low back pain in the controlled trial.
Methods/design
Study design and research question
The trial is embedded in a cohort study that is designed as
a longitudinal, prospective study, which studies the prev-
alence, etiology, severity and prognosis of pregnancy-
related pelvic girdle and/or low back pain until one year
after delivery (Figure 1). The present study is designed as
a pragmatic trial aimed to compare the effects of interven-
tions carried out in primary health care.
We performed a randomized controlled trial in primary
care to determine whether a tailor-made program with
respect to biopsychosocial factors (intervention group)
benefits women with pregnancy-related pelvic girdle and/
or low back pain more in terms of effectiveness and costs
than usual care would on a traditional pain contingent
basis (control group).
Recruitment and informed consent
The medical ethics committee of the Maastricht University
Hospital approved the intervention and cohort study. The
study is performed in the Southeast of the Netherlands.
Midwives and gynecologists recruited the women during
early pregnancy (10–14 weeks). Participation of midwives
and gynecologists in the recruitment of eligible pregnant
women is of major importance for the success of the
cohort and intervention study [13]. We have paid a lot of
attention to difficulties in recruitment such as busy con-
sultation hours and not feasible recruitment procedures.
Therefore, we designed a recruitment protocol that is as
simple as possible, not restrictive, and demanding a min-
imum of time from midwives and gynecologists. Stand-
ardized written information about the cohort and
intervention study is available for every potentially eligi-
ble woman and to be handed out by the midwife or gyne-
cologist. Several steps are taken to encourage participation
of the midwives and gynecologists. We distributed news-
letters about the developments in the cohort and interven-
tion study every three months and visited the practices
and meetings of midwives on a regular basis. Any ques-
tions regarding trial questions received prompt feedback.
The flexibility of the trial procedure is also guaranteed by
assessing potential candidates for the trial at home.
Women are included in the cohort if they are at least 18
years old, pregnant and well versed in Dutch language.
Women are given written information explaining the aims
and contents of the cohort and intervention study before
they decide to participate. Concerning the intervention
study they are told that to current knowledge the twoBMC Public Health 2004, 4:67 http://www.biomedcentral.com/1471-2458/4/67
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investigating treatment options are considered to be
equally effective. The moment of inclusion for the inter-
vention study lies at about three weeks after delivery. An
individual woman enters the intervention study after sign-
ing informed consent for both the cohort and interven-
tion study during early pregnancy and meets the in- and
exclusion criteria of the intervention study three weeks
after delivery. Women are included when having pain in
the pelvic girdle and/or low back with an onset during
pregnancy or just after delivery (cohort data), are
restricted in their normal daily activities because of pelvic
girdle and/or low back pain and if there is a delay in recu-
peration (not yet in the condition to participate satisfac-
tory in housekeeping and care of children because of the
complaints under investigation). The severity of symp-
toms must be varying with physical activities and time
during the day. Women diagnosed with a relevant specific
pathology (such as nerve root pathology, rheumatoid dis-
orders, carcinoma, obstetric complications) that affects
pain and activities of daily life are excluded. Exclusion
also occurs in case of family related or psychosocial prob-
lems or when a disablement procedure is not yet finished.
Final important aspects for in-/exclusion are the willing-
ness of a woman to participate in the study or having a
clear treatment preference[13]. We only included women
who did not indicate such a preference and who were will-
ing to take the 50% risk of receiving a referral to a partici-
pating physiotherapist (and treatment option) or the
freedom of choosing a therapist by themselves (usual
care). Including only women who are naïve (who never
received treatment for their complaints during this preg-
nancy or earlier pregnancies) will result in an unaccepta-
ble reduction in the number of eligible patients. However,
we excluded all the women who already received treat-
ment after their current delivery.
A basic principle for selection of eligible women in this
study is that inclusion criteria must have a meaningful
influence in goal setting for treatment. We therefore
Design of the study Figure 1
Design of the study
Cohort 
n =7526
14 weeks pregnancy Delivery 3 weeks after delivery 1 year after delivery
Enrollment cohort
Baseline measurement 
intervention study
n = 147
Inclusion intervention study
n =126 R
Randomisation
Usual care 
n= 64
Experimental intervention
N- 62
Intervention period
12 weeks after
randomisation
6 months
After delivery
1 year after
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focused on criteria such as a delay in recuperation and
restrictions in normal daily activities caused by preg-
nancy-related pelvic girdle and/or low back pain. How-
ever, other studies in this field formulated inclusion/
exclusion criteria based on certain diagnostic
classification strategies. Although rationales of these strat-
egies greatly differ, they all attach great importance to the
outcomes of particular (albeit different) diagnostic tests.
In the absence of a clear definition and reference standard
to diagnose pregnancy-related pelvic girdle and/or low
back pain, the outcomes of these procedures not only led
to different selections of women having complaints, the
prognostic and diagnostic importance of these subgroups
also remain unclear (Bastiaenen et al. personal
communication).
Exclusion of differential diagnoses is a major point of con-
cern. For that reason we included a history taking and a
physical examination protocol that focuses on differential
diagnoses at first and then on the formulated inclusion
criteria. The various specific physical examination tests to
diagnose pregnancy-related pelvic girdle pain are left
aside. For a better understanding of the complaints and
tailoring treatment, application of these tests has no sup-
plemental value (Bastiaenen et al. personal
communication).
An experienced research-physiotherapist visited women at
home, about three weeks after delivery. This visit is called
for on the basis of a short self-administered questionnaire
and/or initiated by midwives. A positive answer from a
participating woman from the cohort and/or her midwife
on the question: "Do you or does this woman need treat-
ment?" took a central position in these questionnaires. In
advance of a possible home visit, a short history taking by
telephone took place about two weeks after delivery. His-
tory taking focuses on exclusion criteria such as: willing to
participate in this part of the study, a diagnosis with rele-
vant specific pathology, limitations in daily life caused by
pregnancy-related pelvic girdle and/or low back pain and
a delay in recuperation. During a home visit, a standard-
ized history is taken and physical examination to exclude
specific pathology is performed. Self-administered ques-
tionnaires are used to question the women about pain,
limitations in activities, restrictions in participation, pain-
related fear, pain catastrophizing, positive and negative
affectivity, depression, expectancy of treatment result and
quality of life. The questionnaires contain clear instruc-
tions for completion with no help or support from others.
If a woman meets the selection criteria, she is informed
about the aim and method of the intervention study and
if she is willing to participate, the informed consent pro-
cedure is completed. The research-physiotherapist collect-
ing the baseline data is trained in performing the
measurements in a standardized way and is unaware of
the women's treatment assignments.
Randomization and blinding
Randomization takes place after collecting the baseline
data. In this study we used a block randomization (size of
four). An independent research assistant (unaware of the
baseline data) carried out the randomization procedure
according to a random computer-generated list. When a
woman is allocated to the intervention group, the partici-
pating physiotherapist in the environment of the woman
is contacted and we ensured that treatment could start as
soon as possible (within one week). Treatment is covered
for all participants in the intervention group on a
research-physician's referral. Women, allocated to the
usual care group, are free to choose usual treatment by a
(not participating) physiotherapist. Information about a
possible guidance by a general practitioner and feasible
treatments received after randomization is collected by
means of questionnaires in the follow-up period.
Women are blinded to a certain extent to the allocated
treatment because they are kept naïve of the exact content
of both treatment options. Participating physiotherapists
are not blinded to the treatment option but not involved
in the baseline and effect measurements. Researchers deal-
ing with the baseline and outcome data are unaware of the
treatment assignments.
History and physical examination
During a home visit a standardized history is taken [8]
and physical examination is performed. History taking
focuses on on-going pain, its location, intensity and
modalities, variation of symptoms with physical activi-
ties, radiation into the legs, back pain versus leg pain, neu-
rological signs, deformity, obstetric complications, a case
history of low back and pelvic girdle pain prior to this
pregnancy and other differential diagnoses. The format of
the answers is presented as a dichotomous "yes or no".
Demographic characteristics and data about education,
work, income, use of alcohol, smoking, medication, the
onset of pain and functional status during pregnancy have
already been gathered as part of the cohort study at 14 and
30 weeks gestation period and two weeks after delivery.
After history taking a short standardized clinical examina-
tion program is performed, which includes tests of nerve
root radiation (exclusion)[8]. The research-physiothera-
pist fills out the Pain Behavior Scale, a standardized obser-
vation scale for quantifying pain behavior [14,15], after
clinical examination.BMC Public Health 2004, 4:67 http://www.biomedcentral.com/1471-2458/4/67
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Interventions
Usual care
Prior to the trial, detailed information is gathered about
the contents of traditional treatment options. Part of the
information is collected by means of group discussions
with experienced physiotherapists and occupational ther-
apists and interviews on an individual basis with affected
women out of the cohort. An independent rehabilitation
specialist, specialized in pain treatment chaired the
meetings with the therapists. Some subjects for discussion
were: differences in clinical spectrum seen by the thera-
pists, contents of treatment programs during pregnancy
and after delivery, common knowledge by the therapists
about etiology, prognosis and prevalence of the syn-
drome, the optimal time-window for treatment in the
course of complaints and the therapist-patient relation-
ship. Items that provided important topics of conversa-
tion between the therapists were: the moment of taking
up and finishing off treatment, the contents of education
and advice given to the patient and the (lack of) compli-
ance. The most striking characteristics of a traditional
treatment were the character of the therapist-patient rela-
tion and the way of goal setting, focusing on disease man-
agement [16]. There was an explicit professional input
and an accent on biomedical factors. A pain contingent
regimen of avoiding and limiting several day-to-day activ-
ities was important. Compliance and adherence based on
these goals played an important part. Therapists were
often highly concerned about their patient's pain
themselves.
However, interviews with affected women made clear that
most of the women were irritated about this regimen in an
increasing degree after starting the treatment sessions. The
regimen was too strict and on a number of points not
geared to the wishes and concerns of the women. These
aspects caused a lack of compliance and an unremitting
hesitation about a good prognosis and in particular about
reassuming certain day-to-day activities after delivery.
Therapists did not realize the nature of this problem
although they did mention problems with compliance.
Some women were not able to get a grip on their condi-
tion and left management of their pain and activities of
daily life to the therapist. A larger part of the women was
more or less uncertain about picking up their full range of
activities again after delivery. Their beliefs and concerns
about origin and prognosis of their complaints clearly
bore the stamp of the introduced biomedical label. The
relatively favorable prognosis after delivery was largely
unknown to the women as well as to the physiotherapists.
Experimental therapy
Women, allocated to the intervention group, are referred
to a participating physiotherapist in their own neighbor-
hood. These physiotherapists received an educational
course about the treatment protocol prior and during the
study. All physiotherapists were already experienced and
specialized in treating women with pregnancy-related pel-
vic girdle pain prior to the study. The contents of the
experimental therapy are based on the latest literature,
results of interviews with affected women (participating in
the cohort study) and group discussions with experienced
physical and occupational therapists.
A search procedure in literature resulted in various thera-
peutic interventions. However, effectiveness of those
interventions remain unproven. An important common
goal of these treatments is restoration of optimal biome-
chanics, although this is not based on established theoret-
ical principles [7]. The search did not provide enough
possibilities to design a treatment protocol. However, as
mentioned above, results of interviews and group conver-
sations showed interesting contradictions.
During development of the experimental intervention we
focused on the following contradictions: patient-therapist
relationship, education, and hesitation or avoiding of
activities. Theoretical concepts of self-management
[16,17] and fear-avoidance [18] were integrated in the
treatment protocol. A treatment program that demands a
much more active involvement of a participating woman
was designed. Interventions with a self-management
approach are considered to be able to build a bridge
between patients' needs and caregivers' services to meet
those needs. Self-management refers to the individual's
ability to manage the symptoms, treatment, physical and
psychosocial consequences and life style changes inherent
to living with a chronic condition [17]. Self-management
approaches are either group-based or individualized. We
performed an individualized approach of 7–9 sessions of
30 minutes once a week. Standardized information is pre-
sented through a treatment protocol for the therapists and
booklets for the patients [16,19]. Topics included back
and pelvis anatomy, "red flags" indicating a serious med-
ical condition, factors contributing to fluctuations in pain,
appropriate pacing of exercises [12] and activity, handling
pain flare-ups, cognitive restructuring, some graded expo-
sure techniques [18,20,21], communication and social
persuasion. Therapists had to employ problem-solving
techniques that engaged women in identifying day-to-day
problems or limitations related to pelvic girdle and/or low
back pain, setting personal goals, brainstorming options
for achieving these goals and developing personal action
plans. In subsequent sessions, women reviewed their
action plans and their progress towards goals and engaged
in problem-solving skills around difficulties that arose in
trying to implement their plans. Information about two
opposing behavioral responses of pain-related fear
(avoidance and confrontation) is given, and a hierarchy of
individual fear-eliciting movements and activities isBMC Public Health 2004, 4:67 http://www.biomedcentral.com/1471-2458/4/67
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made. Therapists encouraged women in making action
plans for specific activities that were avoided.
Complaint-related problem solving is a key skill. The role
of the therapist is to encourage women to identify possi-
ble causes of a problem, find a number of potential solu-
tions, select one, then try it and finally evaluate the results
and possibly adjust the solution. The second important
key skill is action planning or goal setting. Often a plan
must have been generally unacceptable (such as "go ski-
ing") for a therapist in the usual care. Nevertheless, the
protocol of the experimental intervention embraced the
point of view that a woman is her own best judge of what
is possible. Another major point of action planning is that
a woman could not only receive but also give feedback on
her own accomplishments. Endorsement by the therapist
is very important for a woman to accept her new role. This
way of collaborating with a therapist on short-term action
planning enabled women to master new skills and to
make changes that are realistic and feasible for them.
Therapists also have a role in assisting women in under-
standing their symptoms. Knowledge of the course of the
complaints during pregnancy and after delivery including
pain flare-ups in the year after delivery, factors contribut-
ing to fluctuations in pain, evidence-based knowledge
about etiology and the concept about pain-related fear are
essential. Symptoms are explained as having many but
not alarming causes, which offers the possibility to choose
different actions by the concerning woman. Finally, ther-
apists have a task in practicing social persuasion. A
woman is more likely to change her behavior and have
confidence in doing so if she perceives those around her,
including the therapist to be supportive.
A relationship in which the physiotherapist and the
woman make health care decisions together is the basic
assumption of the intervention. Generally, a time contin-
gent policy is followed in which women set the pace by
means of action plans. The expertise of the physiothera-
pists of the condition in general and of the women about
their own specific condition and lives are equally impor-
tant [22].
Table 1: Timing of measures
Baseline (about 3 weeks 
after delivery)
12 weeks after 
randomization
6 months (after delivery) 1 year (after delivery)
History taking X
Physical Examination: X
PBS X
G P E XXX
M C XXXX
MPQ(VAS) X X X X
RDQ X X X X
Q B P D S XXXX
T S K XXXX
PCS X
BDI X
NEM X
PEM X
Expectancy treatment 
result:
X
S F - 3 6 XXXX
E u r o Q o l XXXX
I P A XXXX
Cost-diary X X X
Satisfaction treatment : X X
Recurrence X X
Co-interventions X
Compliance X X
Subsequent pregnancy : X X
PBS = Pain Behavior Scale GPE = Global erceived Effect MC = Main Complaint MPQ = McGill Pain Questionnaire RDQ = Roland Disability 
Questionnaire QBPDS = Quebec Back Pain Questionnaire TSK = Tampa Scale For Kinesiophobia PCS = Pain Catastrophizing Scale BDI = Beck 
Depression Inventory NEM = Negative Emotionality Scale PEM = Positive Emotionality Scale SF-36 = Short-Form-36 IPA = Impact on Participation 
and AutonomyBMC Public Health 2004, 4:67 http://www.biomedcentral.com/1471-2458/4/67
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Outcome measurements
Outcome measures (Table 1) chosen to explore the suc-
cess of any intervention need to match the desired aims of
that intervention. It is a process in which a standardized
attempt is made to observe an often complex clinical pic-
ture. Primary domain for improvement of the treatment
under investigation is limitations in activities. Other
important domains are the severity of the main com-
plaints, the woman's global feeling of recovery, pain and
participation.
Limitations in activities are measured with the Dutch
translation of the Roland Disability Questionnaire (RDQ)
[23] and the Quebec Back Pain Disability Scale (QBPDS)
[24,25]. We added the phrase "because of my back and/or
pelvic pain" in both questionnaires.
Subjective measurements like global feeling of recovery
(global perceived effect, GPE) and severity of the main
complaints (MC) reflecting a patient-specific approach
are also selected. Global Perceived Effect (GPE) is meas-
ured by self-assessment on a 7-point scale (1 = completely
recovered, 7 = worse than ever). The main complaints
(MC) are selected by the woman in a standardized
approach by selecting three activities, which are an essen-
tial and frequently performed part of her everyday life.
However, the performance is difficult or impossible
because of low back and/or pelvic girdle complaints at the
moment of baseline measurement. Severity of a main
complaint is rated on a visual analog scale (VAS). [26,27].
Pain is measured with two VAS-scales of the McGill Pain
Questionnaire (MPQ-DLV) [28,29] to record the intensity
of pain the last week and day.
The impact on participation and autonomy (IPA) is used
to measure person-perceived restriction in participation
and autonomy [30,31]. The used subscales are autonomy
in self-care, mobility and leisure, social relationships and
family role.
Other important prognostic factors that can influence
treatment results are fear of movement, pain catastrophiz-
ing, depression, negative and positive affect, expectancy of
treatment result and pain behavior.
Fear of movement is measured by the Dutch translation of
the Tampa Scale for Kinesiophobia(TSK)[32,33]. We used
the TSK and the both subscales "fear avoidance" and
"harm"[34,35]
Pain catastrophizing is measured by the Pain Catastro-
phizing Scale (PCS)[36,37].
The Beck Depression Inventory (BDI) [38] measures
depressive symptoms [39]. Analyses of the BDI in this
study did not include items concerning weight loss, sleep-
ing disturbance and work inhibition [40]
To measure the experience of negative affect we used the
14-item Negative Emotionality Scale (NEM) [41]. To
measure positive affect we used the 11-item Positive Emo-
tionality Scale (PEM) [41]. Both are subscales of the Mul-
tidimensional Personality Questionnaire.
Health status is evaluated by the Short-Form 36 (SF-
36)[42,43] and the EuroQol [44]. We used the subscale
"general health".
A cost-diary [45] is used to obtain data on physical activi-
ties, health care utilization, and days of sick leave. Women
are instructed to record costs on a weekly basis until one
year after delivery.
Expectancy of therapy result [46] is measured by means of
a 100 mm visual analog scale (VAS). The woman is asked
to what extent she believes that a treatment is beneficial to
her.
The Pain Behavior Scale (PBS)[14,15] is an observation
scale tapping 8 pain behaviors that the physiotherapist
completes after physical examination. These are verbal
complaints, vocal complaints, facial grimaces, standing
posture, mobility, body language, use of visible support-
ive equipment and stationary movement.
Follow-up
Women are asked to complete follow-up questionnaires
at 12 weeks after randomization, 6 months after delivery
and one year after delivery. Women who did not return
their follow-up questionnaires were contacted by mail or
phone and were asked to continue participation.
Compliance, other interventions and confounding
The follow-up questionnaires ask all women how many
treatment sessions they have followed in the previous
period of time. Furthermore, information on contents,
satisfaction and the aspects of the (experimental) treat-
ment which benefited them most, is gathered. Co-inter-
ventions, medication, aids, additional medical
consumption, recurrence of complaints, return to gainful
employment and a possible subsequent pregnancy are
also registered.
Physiotherapists who treat the participants of the inter-
vention group also answered questions about the number
and contents of the treatment sessions after conducting
the last meeting.BMC Public Health 2004, 4:67 http://www.biomedcentral.com/1471-2458/4/67
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Statistical analyses
Statistical analyses are carried out according to the "inten-
tion-to-treat" approach. The baseline status of the study
groups is compared with respect to the distribution of all
independent prognostic variables and the baseline values
of the outcome variables. For the outcome measures
recorded at baseline and at follow-up, we computed the
difference between the baseline and the follow-up score
for each woman. Differences between groups and 95%CI
are calculated for each outcome measure according to the
intention to treat approach. Primary analysis is done by
means of analysis of an independent t-test (for continu-
ous outcome variables) and chi-square test (for categori-
cal outcome variables). In order to adjust for possible
baseline differences a multiple linear regression analysis
for continuous outcome measures is performed with the
change scores as dependent variable, treatment option as
independent variable and base line scores of the prognos-
tic variables as co-variables. Missing data at the baseline-
measurement are substituted by the "mean of series"
imputation method. Longitudinal missing data are substi-
tuted with the "last value carried forward method". In all
comparisons between the two treatment options a two-
tailed p-value of 0.05 is considered to indicate statistical
significance. Prognostic status at baseline for women with
and without missing values for the outcome variables is
compared for both groups. Analyses are done by using
SPSS statistical software, version 12.0 (SPSS, Inc., Chi-
cago, Illinois). Short term and long term effect analyses
are performed separately.
Economic analyses
A cost-effectiveness analysis compares the costs and
health effects of the experimental intervention to assess
whether it is beneficial from an economic perspective. The
costs of the intervention are calculated separately for the
intervention group. For the whole study group all relevant
health care costs, production loss and patient and family
costs are measured by means of a cost-diary [45] and fol-
low-up questionnaires collected 6 months and one year
after delivery. Both direct health care costs (such as physi-
cian visits, the number of treatment sessions and medica-
tion), direct non-health care costs (such as transport to
therapist) and indirect costs associated to the complaints
(like sick leave, professional as well as voluntary aid and
extra baby sitter) are registered until one year after deliv-
ery. Quality of life is measured using the EuroQol. [44].
For the validation of the healthcare costs, patient and fam-
ily costs, an update of the Dutch manual for costing in
economic evaluations is used. The primary outcome
measure for the cost-effectiveness analysis is the difference
in limitations in activities (RDQ)[23].
Details about enrollment in the study
During the study, 397 of the 7526 women (5%) signed
only for the cohort study (n = 7526) and were therefore
beforehand excluded for taking part in the intervention
study. Throughout pregnancy, 73% of all women in the
cohort reported pain in the lumbar/pelvic region leveling
off to 35.9% three weeks after delivery (Figure 2). The
"three weeks after delivery" prevalence rate of "wanted to
be referred for treatment" was 4.8% at that moment and
remained remarkably stable in the year after delivery.
Since November 2000 (Figure 3), 682 women reported
that they need treatment during pregnancy (9% of the
total cohort). 384 times midwives indicated that a woman
need treatment at the time of 10 days after delivery (5% of
the total cohort). On 197 occasions, both the woman and
her midwife responded positive. The outcomes resulted in
869 possible eligible participants (11.5% of the total
cohort). However, these data resulted in only 147 home
visits, 99 visits indicated by a midwife (67 times in com-
bination with the woman concerned) and 115 indicated
by the woman (Figure 3). On basis of history taking by tel-
ephone, 722 women were excluded from participation.
Ten women did not give informed consent for the inter-
vention study, 3 women moved outside the area interven-
tion was provided, 13 women were excluded because of
specific pathology, 49 women did not want to be rand-
omized (clear treatment preference deviating from the
study protocol) and 12 women did not feel like participa-
tion on second thought. The majority, 635 women, were
excluded because of a quick recovery.
After the home visits, 21 women were excluded. Indicated
by a midwife; one because of family reasons, one because
of specific pathology and two women because of quick
recovery. Indicated by themselves, 17 women were
excluded. Two women because of family and social prob-
lems, one woman because of specific pathology, one
because of a clear treatment preference and 13 women
because of quick recovery.
Eventually, 126 women were included in the intervention
study. 93 times indicated by midwives, 56 times indicated
both by the woman and her midwife and 89 times by
themselves. Finally, only 24.2% of the women indicated
by a midwife were included and 13% indicated by them-
selves. Indicated by both the woman and her midwife,
28.4% was included.
Discussion
This study is designed to evaluate the effectiveness of a tai-
lor-made program with respect to biopsychosocial factors.
A pragmatic design provides the opportunity to evaluate
the value of the experimental intervention without depriv-
ing participating patients of the best current treatmentBMC Public Health 2004, 4:67 http://www.biomedcentral.com/1471-2458/4/67
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option. Including only women who would take the 50%
risk of depriving any treatment at all for their complaints
during the first 12 weeks after delivery was not a realistic
option. The effects of the experimental intervention and
usual care are evaluated as they are applied in primary
health care. It is not feasible to blind a woman to the
applied treatment option, which increases the risk of
information bias. We have tried to minimize this type of
bias by assessing treatment preference before
randomization and excluding women with a clear treat-
ment preference. Details about the enrollment of the trial
underscored this necessity (n = 50 excluded because of a
clear treatment preference). The research-physiotherapist
dealing with the baseline measurement was therefore una-
ware of treatment allocation.
Details about the enrollment out of the cohort into the
trial also show that the start of the experimental interven-
tion is well timed. Most women have complaints during
pregnancy. However, a considerable drop in the number
of women having persistent complaints in the first weeks
after delivery is observed. Then again, numbers of women
having one or more episodes of pain complaints
remained stable in the year after delivery. We have seen
similar trends of proportions of women with a request for
treatment for their complaints during pregnancy (9%),
just after delivery (4.8%) and in the year following
delivery.
The aim of the experimental intervention is to increase the
level of activities. Therefore the primary outcome measure
is limitations in activities. The contrast between both
interventions is an important issue in this study. Major
features that underscore the contrast are the character of
the patient-therapist relationship, pain-contingent versus
time-contingent treatment, compliance to a regime of
avoiding and limiting activities versus action planning
and personal goal setting by the women themselves.
Prevalence of pelvic girdle and/or low back pain during pregnancy and after delivery Figure 2
Prevalence of pelvic girdle and/or low back pain during pregnancy and after delivery
Delivery
Pregnancy From 3 weeks until 1 year after delivery
Cohort
N=7526
9% 4.8%
73 % pain
Wanted to be treated
35.9% pain
Wanted to be treated
After delivery
29.4%
(6 mnds after delivery)
34.4% (one year)BMC Public Health 2004, 4:67 http://www.biomedcentral.com/1471-2458/4/67
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Among therapists, the approach of the experimental inter-
vention is not widespread at all. The participating thera-
pists are explicitly asked to not give any information
about the contents of the experimental treatment to ther-
apists who do not participate in the experimental inter-
vention. It is necessary to interest physiotherapists in the
trial for an efficient performing of the experimental treat-
ment option, which can be achieved by a relevant research
question and in practice applicable results.
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